Menu
Not yet recruiting NCT06605781

Enhancing Psychiatric Nursing Skills in Auditory Hallucination Assessment Via AR/VR and Virtual OSCE

No phase Interventional Randomized Controlled Trial

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: AR/VR technology-based training, traditional vedio and discussion group.
Who it may be relevant to
Registry conditions: Randomized Controlled Trial. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Taiwan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Enhancing Auditory Hallucination Assessment and Intervention Skills of Psychiatric Nursing Student Through AR/VR Technology and OSCE in Virtual Clinical Environments

Overview

The purpose of this study is to develop and evaluate AI-based virtual reality teaching resources aimed at enhancing nursing students' competencies in assessing, communicating with, and managing patients experiencing auditory hallucinations. Specifically, this study seeks to improve the ability of nursing students to effectively assess auditory hallucinations, facilitate better communication with patients experiencing such disturbances, and strengthen their skills in managing these symptoms through the implementation of virtual reality-based educational scenarios.

Detailed description

This study employs a quasi-experimental design and uses a convenience sampling method to select senior students from a university nursing program as participants. The study aims to recruit 150 nursing students. The research involves two institutions, with participants being divided into groups within each institution. The students will be randomly assigned by computer into two groups: an experimental group and a control group. The experimental group will receive AR/VR technology-based group training within a virtual clinical environment during their practicum, while the control group will watch educational videos and participate in a general discussion group focused on auditory hallucinations.

Data will be collected using Google Forms at two time points: baseline and post-intervention. The research instruments include:

1. A self-assessment questionnaire on confidence in auditory hallucination assessment and intervention; 2. A scale measuring nursing students' knowledge, attitudes, and perceived empathy toward auditory hallucinations; 3. The Auditory Hallucination Situational Involvement and Empathy Scale; 4. An OSCE (Objective Structured Clinical Examination) evaluation form that assesses auditory hallucination assessment skills, empathy toward auditory hallucinations, communication skills, and the ability to manage auditory hallucinations." Data will be analyzed using IBM SPSS 24.0 for descriptive statistics and for comparing outcomes between the experimental group and the control group.

Interventions

  • Behavioral AR/VR technology-based training
    Students will receive AR/VR Technology and OSCE in a Virtual Clinical Environment to learn how to assess and manage patients with auditory hallucination. The course was designed as a diverse and interactive learning experience, integrating a virtual clinical environment for auditory hallucinations with the application of Objective Structured Clinical Examination (OSCE). The practicum lasts approximately 15 days, with 8 hours per day. The teaching activities of the course will be held 5 times on
  • Behavioral traditional vedio and discussion group
    Students will receive a traditional course on auditory hallucination assessment, which includes watching educational videos and participating in a general discussion group on auditory hallucinations. The practicum lasts approximately 15 days, with 8 hours per day. The teaching activities of the traditional course will be held 5 times on days 4, 6, 8, 10, and 12 of the practicum.

Primary outcome measures

  • Auditory Hallucination Situational Involvement and Empathy [Time frame: at baseline on day 2 or 3 of the 15-day practicum (T0) and on day 15 of the practicum, three days after the intervention has finished (T1)]
  • OSCE Evaluation Form for Auditory Hallucination Assessment and Intervention [Time frame: at baseline on day 2 or 3 of the 15-day practicum (T0) and on day 15 of the practicum, three days after the intervention has finished (T1)]
  • Self-Assessment Questionnaire on Confidence in Auditory Hallucination Assessment and Intervention [Time frame: at baseline on day 2 or 3 of the 15-day practicum (T0) and on day 15 of the practicum, three days after the intervention has finished (T1)]
  • Nursing Students' Knowledge, Attitudes, and Perceived Empathy Toward Auditory Hallucinations [Time frame: at baseline on day 2 or 3 of the 15-day practicum (T0) and on day 15 of the practicum, three days after the intervention has finished (T1)]

Eligibility criteria

Inclusion criteria

  • Nursing students who are about to undertake their psychiatry practicum.
  • Those who are willing to join the study and sign the consent form.
  • Those who are willing to bring a smartphone to connect with VR360 and watch the video.
  • Those who are willing to use their smartphone for research purposes (a smartphone will be provided by the research team if needed).

Exclusion criteria

  • Individuals with hearing or vision impairments

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Health services research

Study locations

Taiwan · 1 center
  • National Yang Ming Chiao Tung University — Taipei

Identifiers

NCT: NCT06605781 · NYCU113035AEF

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗